Regulation of perforin lysis: Implications for protein disulfide isomerase proteins

Cellular Immunology

Volumn 255, Issue 1-2, 2009, Pages 82-92

  Tamang, David L ^a   Alves, Bryce N ^a   Elliott, Viki ^a   Redelman, Doug ^b   Wadhwa, Renu ^c   Fraser, Stephanie A ^d   Hudig, Dorothy ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d CHARLES RIVER LABORATORIES   (United States)

Author keywords

Cathepsin B; Cytotoxic; Cytotoxicity; Inhibitor; Perforin; Protein disulfide isomerase; T cells

Indexed keywords

CYTOTOXIC REGULATORY PROTEIN 2; GRANZYME; PERFORIN; PROTEIN DISULFIDE ISOMERASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; HEAT SENSITIVITY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CYTOPLASMIC GRANULES; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR CHAPERONES; PERFORIN; PROTEASE INHIBITORS; PROTEIN DISULFIDE-ISOMERASES; RATS; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 59349111169     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.12.001     Document Type: Article

References (56)

1. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., and Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369 (1994) 31-37
2. Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., and Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265 (1994) 528-530
3. Voskoboinik I., Smyth M.J., and Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6 (2006) 940-952
4. Froelich C.J., Orth K., Turbov J., Seth P., Gottlieb R., Babior B., Shah G.M., Bleackley R.C., Dixit V.M., and Hanna W. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271 (1996) 29073-29079
5. Pinkoski M.J., Hobman M., Heibein J.A., Tomaselli K., Li F., Seth P., Froelich C.J., and Bleackley R.C. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood 92 (1998) 1044-1054
6. Pipkin M.E., and Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Curr. Opin. Immunol. 19 (2007) 301-308
7. Bredemeyer A.J., Townsend R.R., and Ley T.J. Use of protease proteomics to discover granzyme B substrates. Immunol. Res. 32 (2005) 143-153
8. Lieberman J., and Fan Z. Nuclear war: the granzyme A-bomb. Curr. Opin. Immunol. 15 (2003) 553-559
9. Lord S.J., Rajotte R.V., Korbutt G.S., and Bleackley R.C. Granzyme B: a natural born killer. Immunol. Rev. 193 (2003) 31-38
10. Trapani J.A., and Sutton V.R. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 15 (2003) 533-543
11. Waterhouse N.J., and Trapani J.A. H is for helper: granzyme H helps granzyme B kill adenovirus-infected cells. Trends Immunol. 28 (2007) 373-375
12. Masson D., and Tschopp J. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J. Biol. Chem. 260 (1985) 9069-9072
13. Podack E.R., and Konigsberg P.J. Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J. Exp. Med. 160 (1984) 695-710
14. Podack E.R., Young J.D., and Cohn Z.A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 82 (1985) 8629-8633
15. Voskoboinik I., and Trapani J.A. Addressing the mysteries of perforin function. Immunol. Cell Biol. 84 (2006) 66-71
16. Bolitho P., Voskoboinik I., Trapani J.A., and Smyth M.J. Apoptosis induced by the lymphocyte effector molecule perforin. Curr. Opin. Immunol. 19 (2007) 339-347
17. Kim J.H., Johannes L., Goud B., Antony C., Lingwood C.A., Daneman R., and Grinstein S. Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc. Natl. Acad. Sci. USA 95 (1998) 2997-3002
18. Montero M., Brini M., Marsault R., Alvarez J., Sitia R., Pozzan T., and Rizzuto R. Monitoring dynamic changes in free Ca2+ concentration in the endoplasmic reticulum of intact cells. EMBO J. 14 (1995) 5467-5475
19. Robert V., De G.F., Massimino M.L., Cantini M., and Pozzan T. Direct monitoring of the calcium concentration in the sarcoplasmic and endoplasmic reticulum of skeletal muscle myotubes. J. Biol. Chem. 273 (1998) 30372-30378
20. Uellner R., Zvelebil M.J., Hopkins J., Jones J., MacDougall L.K., Morgan B.P., Podack E., Waterfield M.D., and Griffiths G.M. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 16 (1997) 7287-7296
21. Voskoboinik I., Thia M.C., Fletcher J., Ciccone A., Browne K., Smyth M.J., and Trapani J.A. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: a critical role for aspartate residues 429, 435, 483, and 485 but not 491. J. Biol. Chem. 280 (2005) 8426-8434
22. Blakely A., Gorman K., Ostergaard H., Svoboda K., Liu C.C., Young J.D., and Clark W.R. Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity. J. Exp. Med. 166 (1987) 1070-1083
23. Verret C.R., Firmenich A.A., Kranz D.M., and Eisen H.N. Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules. J. Exp. Med. 166 (1987) 1536-1547
24. Shinkai Y., Ishikawa H., Hattori M., and Okumura K. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis. Eur. J. Immunol. 18 (1988) 29-33
25. Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., and Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J. Exp. Med. 196 (2002) 493-503
26. Fraser S.A., Karimi R., Michalak M., and Hudig D. Perforin lytic activity is controlled by calreticulin. J. Immunol. 164 (2000) 4150-4155
27. Fraser S.A., Michalak M., Welch W.H., and Hudig D. Calreticulin, a component of the endoplasmic reticulum and of cytotoxic lymphocyte granules, regulates perforin-mediated lysis in the hemolytic model system. Biochem. Cell Biol. 76 (1998) 881-887
28. Andrin C., Pinkoski M.J., Burns K., Atkinson E.A., Krahenbuhl O., Hudig D., Fraser S.A., Winkler U., Tschopp J., Opas M., Bleackley R.C., and Michalak M. Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules. Biochemistry 37 (1998) 10386-10394
29. Winkler U., Fraser S.A., and Hudig D. Perforin-enhancing protein, a low molecular weight protein of cytotoxic lymphocyte granules, enhances perforin lysis. Biochem. Biophys. Res. Commun. 236 (1997) 34-39
30. Baran K., Ciccone A., Peters C., Yagita H., Bird P.I., Villadangos J.A., and Trapani J.A. Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells. J. Biol. Chem. 281 (2006) 30485-30491
31. Woodard S.L., Fraser S.A., Winkler U., Jackson D.S., Kam C.M., Powers J.C., and Hudig D. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis. J. Immunol. 160 (1998) 4988-4993
32. Millard P.J., Henkart M.P., Reynolds C.W., and Henkart P.A. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J. Immunol. 132 (1984) 3197-3204
33. Winkler U., Pickett T.M., and Hudig D. Fractionation of perforin and granzymes by immobilized metal affinity chromatography (IMAC). J. Immunol. Methods 191 (1996) 11-20
34. Ward J.M., and Reynolds C.W. Large granular lymphocyte leukemia. A heterogeneous lymphocytic leukemia in F344 rats. Am. J. Pathol. 111 (1983) 1-10
35. Borregaard N., Heiple J.M., Simons E.R., and Clark R.A. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J. Cell Biol. 97 (1983) 52-61
36. Winkler U., Allison N.J., Woodard S.L., Gault R.A., Ewoldt G.R., Kam C.M., Abuelyaman A., Powers J.C., and Hudig D. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes). Mol. Immunol. 33 (1996) 615-623
37. Voskoboinik I., Thia M.C., De Bono A., Browne K., Cretney E., Jackson J.T., Darcy P.K., Jane S.M., Smyth M.J., and Trapani J.A. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J. Exp. Med. 200 (2004) 811-816
38. Takano S., Wadhwa R., Mitsui Y., and Kaul S.C. Identification and characterization of molecular interactions between glucose-regulated proteins (GRPs) mortalin/GRP75/peptide-binding protein 74 (PBP74) and GRP94. Biochem. J. 357 (2001) 393-398
39. Hudig D., Callewaert D.M., Redelman D., Allison N.J., Krump M., and Tardieu B. Lysis by RNK-16 cytotoxic lymphocyte granules. Rate assays and conditions to study control of cytolysis. J. Immunol. Methods 115 (1988) 169-177
40. Pross H.F., and Maroun J.A. The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68 (1984) 235-249
41. Henkart P.A., Millard P.J., Reynolds C.W., and Henkart M.P. Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J. Exp. Med. 160 (1984) 75-93
42. Young J.D., Damiano A., DiNome M.A., Leong L.G., and Cohn Z.A. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin). J. Exp. Med. 165 (1987) 1371-1382
43. Hendershot L.M., Valentine V.A., Lee A.S., Morris S.W., and Shapiro D.N. Localization of the gene encoding human BiP/GRP78, the endoplasmic reticulum cognate of the HSP70 family, to chromosome 9q34. Genomics 20 (1994) 281-284
44. Kaul S.C., Aida S., Yaguchi T., Kaur K., and Wadhwa R. Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. J. Biol. Chem. 280 (2005) 39373-39379
45. Shinkai Y., Takio K., and Okumura K. Homology of perforin to the ninth component of complement (C9). Nature 334 (1988) 525-527
46. Young J.D., Cohn Z.A., and Podack E.R. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science 233 (1986) 184-190
47. Pilzer D., Gasser O., Moskovich O., Schifferli J.A., and Fishelson Z. Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin. Immunopathol. 27 (2005) 375-387
48. Pilzer D., and Fishelson Z. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Int. Immunol. 17 (2005) 1239-1248
49. Turano C., Coppari S., Altieri F., and Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J. Cell Physiol. 193 (2002) 154-163
50. Hirano N., Shibasaki F., Sakai R., Tanaka T., Nishida J., Yazaki Y., Takenawa T., and Hirai H. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur. J. Biochem. 234 (1995) 336-342
51. Baksh S., Burns K., Andrin C., and Michalak M. Interaction of calreticulin with protein disulfide isomerase. J. Biol. Chem. 270 (1995) 31338-31344
52. Oliver J.D., Roderick H.L., Llewellyn D.H., and High S. ERp57 functions as a subunit of specific complexes formed with the ER lectins calreticulin and calnexin. Mol. Biol. Cell 10 (1999) 2573-2582
53. Zapun A., Darby N.J., Tessier D.C., Michalak M., Bergeron J.J., and Thomas D.Y. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem. 273 (1998) 6009-6012
54. Andres D.A., Rhodes J.D., Meisel R.L., and Dixon J.E. Characterization of the carboxyl-terminal sequences responsible for protein retention in the endoplasmic reticulum. J Biol. Chem. 266 (1991) 14277-14282
55. Tschopp J., Masson D., Schafer S., Peitsch M., and Preissner K.T. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities. Biochemistry 27 (1988) 4103-4109
56. Matsuda K., Ishiura S., Koizumi H., Kawasaki H., Arahata K., and Sugita H. Apolipoprotein B is a major perforin inhibitor protein in human serum. Mol. Immunol. 28 (1991) 1211-1216